| Autor: |
da Silva PB; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. patrbent@yahoo.com.br., Bonifácio BV; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. brunavidalb@gmail.com., Frem RC; Chemistry Institute, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14800-060 São Paulo, Brazil. rcgfrem@gmail.com., Godoy Netto AV; Chemistry Institute, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14800-060 São Paulo, Brazil. adelino@iq.unesp.br., Mauro AE; Chemistry Institute, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14800-060 São Paulo, Brazil. mauro@iq.unesp.br., Ferreira AM; Chemistry Institute, USP-University São Paulo, Campus São Paulo, São Paulo, 05508-900 São Paulo, Brazil. amdcferr@iq.usp.br., Lopes Ede O; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. ericalopes276@gmail.com., Raddi MS; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. raddims@fcfar.unesp.br., Bauab TM; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. tmbauab@gmail.com., Pavan FR; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. fernandopavan@fcfar.unesp.br., Chorilli M; School of Pharmaceutical Sciences, UNESP-University Estadual Paulista, Campus Araraquara, Araraquara, 14801-902 São Paulo, Brazil. chorilli@fcfar.unesp.br. |
| Abstrakt: |
The aim of this study was to construct a nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes. New compounds with the general formulae [CuX₂(INH)₂]·nH₂O (X = Cl(-) and n = 1 (1); X = NCS(-) and n = 5 (2); X = NCO(-) and n = 4 (3); INH = isoniazid, a drug widely used to treat tuberculosis) derived from the reaction between the copper(II) chloride and isoniazid in the presence or absence of pseudohalide ions (NCS(-) or NCO(-)) were synthesized and characterized by infrared spectrometry, electronic absorption spectroscopy, electron paramagnetic resonance (EPR) spectroscopy, elemental analysis, melting points and complexometry with 2,2',2'',2'''-(Ethane-1,2-diyldinitrilo)tetraacetic acid (EDTA). The characterization techniques allowed us to confirm the formation of the copper(II) complexes. The Cu(II) complexes were loaded into microemulsion (MEs) composed of 10% phase oil (cholesterol), 10% surfactant [soy oleate and Brij(®) 58 (1:2)] and 80% aqueous phase (phosphate buffer pH = 7.4) prepared by sonication. The Cu(II) complex-loaded MEs displayed sizes ranging from 158.0 ± 1.060 to 212.6 ± 1.539 nm, whereas the polydispersity index (PDI) ranged from 0.218 ± 0.007 to 0.284 ± 0.034. The antibacterial activity of the free compounds and those that were loaded into the MEs against Staphylococcus aureus ATCC(®) 25923 and Escherichia coli ATCC(®) 25922, as evaluated by a microdilution technique, and the cytotoxicity index (IC50) against the Vero cell line (ATCC(®) CCL-81(TM)) were used to calculate the selectivity index (SI). Among the free compounds, only compound 2 (MIC 500 μg/mL) showed activity for S. aureus. After loading the compounds into the MEs, the antibacterial activity of compounds 1, 2 and 3 was significantly increased against E. coli (MIC's 125, 125 and 500 μg/mL, respectively) and S. aureus (MICs 250, 500 and 125 μg/mL, respectively). The loaded compounds were less toxic against the Vero cell line, especially compound 1 (IC50 from 109.5 to 319.3 μg/mL). The compound 2- and 3-loaded MEs displayed the best SI for E. coli and S. aureus, respectively. These results indicated that the Cu(II) complex-loaded MEs were considerably more selective than the free compounds, in some cases, up to 40 times higher. |
